Recently, many literatures suggested that SNHG1 was upregulated in various malignant tumors, such as gastric cancer, renal cell carcinoma, and nasopharyngeal carcinoma.[15,30,31] SNHG1 was reported to be involved in cancer cell proliferation, apoptosis, invasion, and epithelial-mesenchymal transition. This evidence concerns the gene SNHG1 and renal cell carcinoma.